Back | Next |
home / stock / ino / ino message board
Subject | By | Source | When |
---|---|---|---|
Either Inovio is planning something big with another | smoke_em | investorshub | 03/08/2023 4:23:46 PM |
This registration statement contains: . a base prospectus which | gew59 | investorshub | 03/08/2023 3:57:04 PM |
4 doses of $INO-3107 and look at these | smoke_em | investorshub | 03/08/2023 3:19:14 PM |
cervical high grade intraepithelial lesions are not cancer. | doc2016 | investorshub | 03/08/2023 1:46:09 PM |
$INO Inovio would do very well to follow | MiamiGent | investorshub | 03/03/2023 2:34:52 PM |
"$INO" new management believes that its current research | smoking guns | investorshub | 03/01/2023 9:36:08 PM |
Yahoo may be following Stock Twits lead. Stock | MiamiGent | investorshub | 02/27/2023 1:52:25 AM |
moderna and keytruda pr. but is moderna | doc2016 | investorshub | 02/23/2023 3:21:49 PM |
At least your eyes are wide open. Way | MiamiGent | investorshub | 02/22/2023 2:34:50 AM |
Luckily, I never bought into the hype over | drkazmd65 | investorshub | 02/21/2023 9:10:47 PM |
Yet another word salad PR from Inovio, king | MiamiGent | investorshub | 02/18/2023 2:52:24 AM |
Good news? I'm not a subscriber to | drkazmd65 | investorshub | 02/16/2023 1:37:48 PM |
OK??? | smoking guns | investorshub | 02/13/2023 4:41:45 PM |
dd Melloddy. a group of pharma organizing | doc2016 | investorshub | 02/09/2023 3:26:29 AM |
After 45 years of fleecing investors, a share | MiamiGent | investorshub | 01/30/2023 11:50:24 PM |
This World: Will a cure for cancer come | KPIFF-LDDFF | investorshub | 01/28/2023 6:50:42 PM |
roche and inovio on pd-l1 inhibitor | doc2016 | investorshub | 01/20/2023 12:08:26 PM |
What does this gobbly gook have to do | MiamiGent | investorshub | 01/12/2023 1:37:11 AM |
genomics and nucleotides, the novocure transducers creating the | doc2016 | investorshub | 01/11/2023 3:23:23 AM |
I'd suggest peeling this announcement back. Advaccine has | Opus X | investorshub | 01/05/2023 6:53:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer PR Newswire Mr. Egge brings over 25 years of biopharmaceutical experience building commercial organizations and successfully launching novel therapeutic products INOVIO poised to become a commercia...
INOVIO Added to Russell 2000® Index Effective July 1, 2024 PR Newswire PLYMOUTH MEETING, Pa. , July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect p...
Company executes capital structure management initiative to reduce total debt by purchasing for cash and exchanging for long-term debt and equity, $125 million of face value, or nearly 80% of outstanding convertible notes, at 30% discount Inseego Corp. (Nasdaq: INSG) (the “Compan...